Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Insights
  2. Events
  3. About
  4. Contact Us
MAIN/search
MAIN/Insights
Insights/
Our Latest Whitepapers

Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific. 

Learn More
Blogs, Case Studies & Podcasts

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

Discover Insights

IQVIA APAC Insight

"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.

Read The Latest Issue
MAIN/Events
Events/
Upcoming Events & Webinars

View our upcoming events and webinars.

Explore The Latest
On-Demand Webinars

Visit our library of on-demand webinars.

Discover Insights

Featured Event

"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers

Learn More
MAIN/About
About/
Newsroom

Read the latest updates and press releases.

Learn More
Career Opportunities

Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search Jobs

APAC FOOTPRINT

"Explore our Asia Pacific locations.

Learn more
MAIN/Contact Us
Contact Us/
White Paper
Testing the CAR Risk mitigation in autologous CAR-T therapy clinical trials in oncology
Jan 13, 2023
  • Locations
  • Asia Pacific
  • Testing the CAR Risk mitigation in autologous CAR-T therapy clinical trials in oncology

Get instant access

Download

Activity in the field of Cell and Gene Therapy (CAGT) has been steadily increasing as the techniques are refined, and patient selection and monitoring are standardized. This white paper builds on the first paper in the CAGT Hot Buttons series, “Introduction to Autologous CAR-T therapy”. Here, we discuss frequently encountered medical hazards of the most widely available autologous Chimeric Antigen Receptor T-cell (CAR-T) therapies in the B cell hematologic malignancy patient population.

WHITE PAPER

Starting the CAR An Introduction To Autologous CAR-T Therapy

The IQVIA CAGT Hot Buttons series covers basic concepts in CAGT for newcomers to this field. In this whitepaper, we summarize the CAR-T regulatory status from Asia-Pacific markets, basics of CAR-T receptor structure and look at the common toxicities of currently available CAR-T therapies which have regulatory approval for hematological malignancies.
LEARN MORE
Contact Us